Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors: Design, Synthesis,

详细信息    查看全文

• 作者：Stefania Butini ; Sandra Gemma ; Giuseppe Campiani ; Silvia Franceschini ; Francesco Trotta ; Marianna Borriello ; Nicoletta Ceres ; Sindu Ros ; Salvatore Sanna Coccone ; Matteo Bernetti ; Meri De Angelis ; Marg
• 刊名：Journal of Medicinal Chemistry
• 出版年：2009
• 出版时间：January 8, 2009
• 年：2009
• 卷：52
• 期：1
• 页码：151-169
• 全文大小：483K
• 年卷期：v.52,no.1(January 8, 2009)
• ISSN：1520-4804

文摘

Dopamine D₃ antagonism combined with serotonin 5-HT_1A and 5-HT_2A receptor occupancy may represent a novel paradigm for developing innovative antipsychotics. The unique pharmacological features of 5i are a high affinity for dopamine D₃, serotonin 5-HT_1A and 5-HT_2A receptors, together with a low affinity for dopamine D₂ receptors (to minimize extrapyramidal side effects), serotonin 5-HT_2C receptors (to reduce the risk of obesity under chronic treatment), and for hERG channels (to reduce incidence of torsade des pointes). Pharmacological and biochemical data, including specific c-fos expression in mesocorticolimbic areas, confirmed an atypical antipsychotic profile of 5i in vivo, characterized by the absence of catalepsy at antipsychotic dose.